• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌少症和全身炎症标志物在接受食管癌根治性放疗患者中的预后价值

Prognostic Value of Sarcopenia and Systemic Inflammation Markers in Patients Undergoing Definitive Radiotherapy for Esophageal Cancer.

作者信息

Liang Huanwei, Peng Huajian, Chen Long

机构信息

Department of Radiotherapy, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.

Department of Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.

出版信息

Cancer Manag Res. 2021 Jan 11;13:181-192. doi: 10.2147/CMAR.S288522. eCollection 2021.

DOI:10.2147/CMAR.S288522
PMID:33469362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7810973/
Abstract

OBJECTIVE

To determine the independent and combined prognostic value of sarcopenia and systemic inflammatory markers in esophageal cancer patients undergoing definitive radiotherapy.

METHODS

Sarcopenia was diagnosed on the basis of the skeletal muscle index (SMI) as determined by the skeletal muscle area at the third lumbar (L3) region and body height. The optimal cutoff value of systemic inflammatory markers was determined by the receiver-operating curve (ROC). Logistic regression was used to analyze the correlation among different variables. Cox proportional hazards model was used to identify the factors significantly correlated to overall survival (OS). Based on the results of multivariate survival analysis, a nomogram was established to predict the survival rate. The accuracy of the nomogram was evaluated by the coordination index and the calibration curve.

RESULTS

A total of 100 esophageal cancer patients were included, of which 77 exhibited sarcopenia. The lymphocyte-monocyte ratio (LMR) was significantly correlated to the risk of sarcopenia (OR = 0.637, 95% CI, 0.452-0.898, P = 0.010). In addition, sarcopenia (P = 0.002, HR = 3.991, 95% CI: 1.653-9.638) and LMR < 2.67 (P < 0.001, HR = 2.665, 95% CI: 1.563-4.543) were independent predictors of OS. Two nomograms with good predictive accuracy were established.

CONCLUSION

Sarcopenia and LMR can independently predict the survival of patients with esophageal cancer receiving definitive radiotherapy and have good combined prognostic value.

摘要

目的

确定肌肉减少症和全身炎症标志物对接受根治性放疗的食管癌患者的独立及联合预后价值。

方法

根据第三腰椎(L3)区域的骨骼肌面积和身高确定的骨骼肌指数(SMI)来诊断肌肉减少症。通过受试者操作特征曲线(ROC)确定全身炎症标志物的最佳临界值。采用逻辑回归分析不同变量之间的相关性。使用Cox比例风险模型确定与总生存期(OS)显著相关的因素。基于多变量生存分析结果,建立列线图以预测生存率。通过一致性指数和校准曲线评估列线图的准确性。

结果

共纳入100例食管癌患者,其中77例存在肌肉减少症。淋巴细胞与单核细胞比值(LMR)与肌肉减少症风险显著相关(OR = 0.637,95%CI:0.452 - 0.898,P = 0.010)。此外,肌肉减少症(P = 0.002,HR = 3.991,95%CI:1.653 - 9.638)和LMR < 2.67(P < 0.001,HR = 2.665,95%CI:1.563 - 4.543)是OS的独立预测因素。建立了两个预测准确性良好的列线图。

结论

肌肉减少症和LMR可独立预测接受根治性放疗的食管癌患者的生存情况,并具有良好的联合预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/d96173c8cf84/CMAR-13-181-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/ebdef76a21ce/CMAR-13-181-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/ef4e56bc9a3f/CMAR-13-181-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/77c6ea829d09/CMAR-13-181-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/2c6f97bc2503/CMAR-13-181-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/d96173c8cf84/CMAR-13-181-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/ebdef76a21ce/CMAR-13-181-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/ef4e56bc9a3f/CMAR-13-181-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/77c6ea829d09/CMAR-13-181-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/2c6f97bc2503/CMAR-13-181-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/7810973/d96173c8cf84/CMAR-13-181-g0005.jpg

相似文献

1
Prognostic Value of Sarcopenia and Systemic Inflammation Markers in Patients Undergoing Definitive Radiotherapy for Esophageal Cancer.肌少症和全身炎症标志物在接受食管癌根治性放疗患者中的预后价值
Cancer Manag Res. 2021 Jan 11;13:181-192. doi: 10.2147/CMAR.S288522. eCollection 2021.
2
Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.骨骼肌指数和全身炎症指数对淋巴结阳性乳腺癌根治术后患者的预后意义。
BMC Cancer. 2022 Mar 3;22(1):234. doi: 10.1186/s12885-022-09312-x.
3
Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy.根治性胃切除术后肌少症和全身炎症对胃癌患者的预后价值及相关性。
Oncologist. 2019 Nov;24(11):e1091-e1101. doi: 10.1634/theoncologist.2018-0651. Epub 2019 Mar 25.
4
The Prognostic Significance of Sarcopenia and the Neutrophil-to-Lymphocyte Ratio in Elderly Patients with Esophageal Squamous Cell Carcinoma.老年食管鳞状细胞癌患者中肌肉减少症和中性粒细胞与淋巴细胞比值的预后意义
Cancer Manag Res. 2021 Apr 13;13:3209-3218. doi: 10.2147/CMAR.S302274. eCollection 2021.
5
The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy.体成分状况与全身炎症标志物联合对接受辅助放化疗的胃癌患者具有预后价值。
Nutrition. 2022 Jan;93:111464. doi: 10.1016/j.nut.2021.111464. Epub 2021 Sep 17.
6
Prognostic Value of Body Composition and Systemic Inflammatory Markers in Patients with Locally Advanced Cervical Cancer Following Chemoradiotherapy.局部晚期宫颈癌患者放化疗后身体组成和全身炎症标志物的预后价值
J Inflamm Res. 2023 Nov 10;16:5145-5156. doi: 10.2147/JIR.S435366. eCollection 2023.
7
Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival.肿瘤和外周血中相互交织的白细胞平衡可作为左右侧结直肠癌生存的有力预测指标。
World J Gastrointest Oncol. 2022 Jan 15;14(1):295-318. doi: 10.4251/wjgo.v14.i1.295.
8
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.放射化学治疗局部晚期食管癌患者中肌肉减少症的预后价值。
Radiat Oncol. 2020 May 22;15(1):116. doi: 10.1186/s13014-020-01545-z.
9
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.骨骼肌量迅速下降预示经导管肝动脉内治疗的肝细胞癌预后不良。
BMC Cancer. 2018 Jul 24;18(1):756. doi: 10.1186/s12885-018-4673-2.
10
The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.术后肝内胆管癌患者肌少症联合术前纤维蛋白原-白蛋白比值的预后价值:一项多中心前瞻性研究。
Cancer Med. 2021 Jul;10(14):4768-4780. doi: 10.1002/cam4.4035. Epub 2021 Jun 8.

引用本文的文献

1
Computed tomography-based body composition and systemic inflammation for outcome prediction in patients with resectable esophageal squamous cell carcinoma.基于计算机断层扫描的身体成分和全身炎症对可切除食管鳞状细胞癌患者预后的预测作用
J Thorac Dis. 2025 Apr 30;17(4):2441-2452. doi: 10.21037/jtd-2025-508. Epub 2025 Apr 28.
2
Methods for diagnosing malnutrition in patients with esophageal cancer, and the association with nutritional and inflammatory indices: A cross‑sectional study.食管癌患者营养不良的诊断方法及其与营养和炎症指标的关联:一项横断面研究
Oncol Lett. 2025 Mar 5;29(5):223. doi: 10.3892/ol.2025.14969. eCollection 2025 May.
3

本文引用的文献

1
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).IV期非小细胞肺癌(NSCLC)的预后生物标志物:中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)、血小板与淋巴细胞比值(PLR)以及晚期肺癌炎症指数(ALI)。
Transl Lung Cancer Res. 2019 Dec;8(6):886-894. doi: 10.21037/tlcr.2019.11.16.
2
Associations between skeletal muscle mass index, nutritional and functional status of patients with oesophago-gastric cancer.食管胃癌患者骨骼肌质量指数与营养及功能状态之间的关联
Clin Nutr ESPEN. 2019 Dec;34:61-67. doi: 10.1016/j.clnesp.2019.08.012. Epub 2019 Sep 10.
3
Impacts of sarcopenia on adverse events and prognosis in Chinese patients with esophageal cancer undergoing chemoradiotherapy.
肌少症对接受放化疗的中国食管癌患者不良事件及预后的影响
Front Nutr. 2025 Feb 20;12:1523674. doi: 10.3389/fnut.2025.1523674. eCollection 2025.
4
Prognostic value of lymphocyte to monocyte ratio in patients with esophageal cancer: a systematic review and meta-analysis.淋巴细胞与单核细胞比值在食管癌患者中的预后价值:一项系统评价和荟萃分析
Front Oncol. 2024 Nov 26;14:1401076. doi: 10.3389/fonc.2024.1401076. eCollection 2024.
5
Sarcopenia accompanied by systemic inflammation can predict clinical outcomes in patients with head and neck cancer undergoing curative therapy.伴有全身炎症的肌肉减少症可预测接受根治性治疗的头颈癌患者的临床结局。
Front Oncol. 2024 Mar 14;14:1378762. doi: 10.3389/fonc.2024.1378762. eCollection 2024.
6
Emerging markers of cancer cachexia and their relationship to sarcopenia.癌症恶病质的新兴标志物及其与肌肉减少症的关系。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17511-17527. doi: 10.1007/s00432-023-05465-9. Epub 2023 Oct 31.
7
Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis.老年食管癌远处转移患者不同治疗策略的预后分析及治疗利用情况:一项监测、流行病学和最终结果(SEER)数据库分析
J Cancer Res Clin Oncol. 2023 Nov;149(17):15413-15423. doi: 10.1007/s00432-023-05260-6. Epub 2023 Aug 29.
8
Inflammatory biomarkers as predictors of immune activation to different irradiated sites and short-term efficacy in advanced squamous cell esophageal carcinoma received radioimmunotherapy.炎症生物标志物作为晚期食管鳞状细胞癌接受放射免疫治疗时对不同照射部位免疫激活及短期疗效的预测指标。
Front Oncol. 2023 May 10;13:1117648. doi: 10.3389/fonc.2023.1117648. eCollection 2023.
9
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment.癌症患者治疗前肌少症:癌症治疗期间患病率和预测价值的最新荟萃分析。
Nutrients. 2023 Feb 27;15(5):1193. doi: 10.3390/nu15051193.
10
The evaluation of the association between preoperative sarcopenia and postoperative pneumonia and factors for preoperative sarcopenia in patients undergoing thoracoscopic-laparoscopic esophagectomy for esophageal cancer.术前骨骼肌减少症与术后肺炎的相关性评估以及行胸腔镜腹腔镜食管癌切除术的患者术前骨骼肌减少症的相关因素。
Surg Today. 2023 Jul;53(7):782-790. doi: 10.1007/s00595-022-02620-6. Epub 2023 Jan 10.
Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal Cancer.肌少症在不可切除的晚期食管癌患者中的预后意义
J Clin Med. 2019 Oct 9;8(10):1647. doi: 10.3390/jcm8101647.
4
Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer.肌少症是否比身体质量指数更能预测并发症?直肠癌患者的肌少症与手术结果。
Colorectal Dis. 2019 Dec;21(12):1372-1378. doi: 10.1111/codi.14751. Epub 2019 Jul 21.
5
Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer.食管癌同步放化疗患者肌肉减少症与预后的关系
Front Oncol. 2019 May 8;9:366. doi: 10.3389/fonc.2019.00366. eCollection 2019.
6
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis.诊断时淋巴细胞-单核细胞比值对霍奇金淋巴瘤的预后价值:一项荟萃分析。
BMC Cancer. 2019 Apr 11;19(1):338. doi: 10.1186/s12885-019-5552-1.
7
Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy.根治性胃切除术后肌少症和全身炎症对胃癌患者的预后价值及相关性。
Oncologist. 2019 Nov;24(11):e1091-e1101. doi: 10.1634/theoncologist.2018-0651. Epub 2019 Mar 25.
8
Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study.肌肉减少症作为消化道癌症腹部手术后不良手术和肿瘤学结局的预测指标:一项前瞻性队列研究。
Clin Nutr. 2019 Dec;38(6):2881-2888. doi: 10.1016/j.clnu.2018.12.025. Epub 2018 Dec 29.
9
Prevalence of Sarcopenia and Its Relationship with Nutritional State and Quality of Life in Patients with Digestive Diseases.消化系统疾病患者中肌肉减少症的患病率及其与营养状况和生活质量的关系。
J Nutr Sci Vitaminol (Tokyo). 2018;64(6):445-453. doi: 10.3177/jnsv.64.445.
10
Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer.肌肉减少症和全身炎症反应在食管癌患者中的预后意义
Anticancer Res. 2019 Jan;39(1):449-458. doi: 10.21873/anticanres.13133.